Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus midazolam + pethidine sedation for endoscopy
IRCT2017070834959N1Phase 4Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol, midazolam and pethidine in None and esophagogastroduodenoscopy (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Effects of sedation and Side effects of sedation. Started Sep 2017; status: completed.
02
Drugs
propofolmidazolampethidine
03
Conditions
esophagogastroduodenoscopy
Beyond the preview
Go deeper on IRCT2017070834959N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017070834959N1.